These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival. Brown JM, Rakoczy K, Pretell-Mazzini J. Cancer Treat Res Commun; 2022; 31():100530. PubMed ID: 35144048 [Abstract] [Full Text] [Related]
32. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases. Giner F, López-Guerrero JA, Machado I, Rubio-Martínez LA, Espino M, Navarro S, Agra-Pujol C, Ferrández A, Llombart-Bosch A. Virchows Arch; 2023 Feb 01; 482(2):407-417. PubMed ID: 36376703 [Abstract] [Full Text] [Related]
33. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group. Paioli A, Stacchiotti S, Campanacci D, Palmerini E, Frezza AM, Longhi A, Radaelli S, Donati DM, Beltrami G, Bianchi G, Barisella M, Righi A, Benini S, Fiore M, Picci P, Gronchi A. Ann Surg Oncol; 2021 Feb 01; 28(2):1142-1150. PubMed ID: 32572850 [Abstract] [Full Text] [Related]
36. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Jakowski JD, Wakely PE. Cancer; 2007 Oct 25; 111(5):298-305. PubMed ID: 17676582 [Abstract] [Full Text] [Related]
37. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma. Yoshida A, Makise N, Wakai S, Kawai A, Hiraoka N. Mod Pathol; 2018 May 25; 31(5):744-752. PubMed ID: 29327709 [Abstract] [Full Text] [Related]